denosumab-bnht

denosumab-bnht (CONEXXENCE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

CONEXXENCE is a marketed brand name for denosumab-bnht. Check FDA Drugs@FDA for the current US label holder and prescribing information.

denosumab-bnht has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.